Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Anastrozole

Anastrozole

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Anastrozole

54 trials tracked of Anastrozole: 15 in phase 3 or 4 and 2 with published results. The most-cited published study has 1020 citations.

54Trials tracked
15Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 3 Phase 3 12 Phase 2 29 Phase 1 5 Other / NA 5
  1. Phase 3 Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid Completed · 1,020 cited
  2. Phase 3 Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors Completed · 713 cited
  3. Phase 4 Liver Safety Under Upfront Arimidex vs Tamoxifen Completed
  4. Phase 4 Arthralgia During Anastrozole Therapy for Breast Cancer Completed
  5. Phase 4 Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole Completed
  6. Phase 3 Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ Completed
Show 44 more trials
  1. Phase 3 Secondary Adjuvant Long Term Study With Arimidex Completed
  2. Phase 3 Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer Completed
  3. Phase 3 Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer Completed
  4. Phase 3 Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Completed
  5. Phase 3 Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer Completed
  6. Phase 3 S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer Completed
  7. Phase 3 Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy Completed
  8. Phase 3 Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer Completed
  9. Phase 3 Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy Completed
  10. Phase 2 Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer Completed
  11. Phase 2 Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. Completed
  12. Phase 2 A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer Completed
  13. Phase 2 A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery Completed
  14. Phase 2 ITT4 Intratesticular Hormonal Milieu in Man (ITT4) Completed
  15. Phase 2 Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis Completed
  16. Phase 2 Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] Completed
  17. Phase 2 Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer Completed
  18. Phase 2 Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer Completed
  19. Phase 2 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Giredestrant Plus Palbociclib Compared With Anastrozole Plus Palbociclib for Postmenopausal Women With Estrogen Receptor-Positive and HER2-Negative Untreated Early Breast Cancer (coopERA Breast Cancer) Completed
  20. Phase 2 Pulmonary Hypertension and Anastrozole Trial Completed
  21. Phase 2 Chemoprevention Trial - Anastrozole in Ductal Carcinoma In Situ (DCIS) in Postmenopausal Women Completed
  22. Phase 2 Bay98-7196, Dose Finding / POC Study Completed
  23. Phase 2 Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer Completed
  24. Phase 2 Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer Completed
  25. Phase 2 Primary Chemotherapy With Docetaxel-Capecitabine and Doxorubicin-Cyclophosphamide in Breast Cancer Completed
  26. Phase 2 Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer Completed
  27. Phase 2 Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer Completed
  28. Phase 2 Anastrozole Administration in Elderly Hypogonadal Men Completed
  29. Phase 2 Anastrozole in Patients With Pulmonary Arterial Hypertension Completed
  30. Phase 2 Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women Completed
  31. Phase 2 A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer Completed
  32. Phase 2 Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer Completed
  33. Phase 2 A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer Completed
  34. Phase 2 A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer Completed
  35. Phase 2 Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer Completed
  36. Phase 2 Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer Completed
  37. Phase 2 Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer Completed
  38. Phase 2 A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer Completed
  39. Phase 1 This Study in Patients With Different Types of Cancer (Solid Tumours) Aims to Find a Safe Dose of Xentuzumab in Combination With Abemaciclib With or Without Hormonal Therapies. The Study Also Tests How Effective These Medicines Are in Patients With Lung and Breast Cancer Completed
  40. Phase 1 Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer Completed
  41. Phase 1 Anastrozole 1 mg Tablets Under Fed Conditions Completed
  42. Phase 1 To Assess Safety and Effect of Olaparib on the Pharmacokinetics of Anastrozole, Letrozole & Tamoxifen, and Their Effect on Olaparib, in Patients With Advanced Solid Cancer Completed
  43. Phase 1 Anastrozole 1 mg Tablets Under Fasting Conditions Completed
  44. N/A Pre-Surgical Intervention for Targeted Therapies for Breast Cancer Completed

Showing the 50 most-cited and recently-updated of 54 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.